Remove Designs Remove Ownership Remove Patent Remove Public Use
article thumbnail

Empowering Innovation: The Role of Intellectual Property in Technology Transfer

IP and Legal Filings

Its gained momentum with the advent of importance in R&D and patent registration. It’s the first important step towards protecting owner’s rights and its lawful public use. The transfer is facilitated in India by the Indian Patent office. Well, it helps in commercialisation of the invention by allowing its public use.

article thumbnail

Precedential No. 34: "IFG" Fails to Function as a Trademark For Live Plants Because It's a Varietal Name

The TTABlog

The CAFC explained that an entity that is the source of a varietal may use a particular term as a trademark for its specific varietal, but it must be clear that there is also a generic name for the varietal. This notion reflects the Board’s earlier decisions that if the term is used as a designation of source (i.e.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Intellectual Property Tools for Protecting Fashion Goods

LexBlog IP

Below are three possible situations in which you can use intellectual property tools with respect to a product’s nature, originality, consumer driven features, and potential for growth. In the event that infringement occurs, a designer must show that the infringer copied the designers copyrighted work. [5] ” [8].

article thumbnail

Intellectual Property Tools for Protecting Fashion Goods

Above the Fold

Below are three possible situations in which you can use intellectual property tools with respect to a product’s nature, originality, consumer driven features, and potential for growth. In the event that infringement occurs, a designer must show that the infringer copied the designers copyrighted work. [5]

article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

The biosimilar pathway was designed to increase competition for biologics and reduce healthcare costs. Note that FDA still has not designated any biosimilar as interchangeable to its reference product. As noted above, companies are already taking advantage of these new designations. Introduction.